Introduction: Currently, relatively rare complications of the early twentieth century, placenta accretes was transformed into perhaps the most common obstetric pathology requiring removal of the uterus. In the modern development of endovascular surgery becomes possible to significantly reduce the blood loss during childbirth and to preserve fertility. Material and methods:The paper presents the experience of using endovascular methods to reduce blood loss. Depending on the kind of care for endovascular patients were divided into two groups. The first group (n=38) consisted of patients whose delivery is accompanied by temporary balloon occlusion of the common iliac arteries on both sides, and the second group (n=59) -the patient underwent embolization of the uterine arteries.Results: Patients in both groups the use of modern technology -temporary balloon occlusion of the common iliac arteries and embolization of the uterine arteries in conjunction with hardware reinfusion of autologous eritrotsity-allowed to perform organsparing surgery all patients. The average intraoperative blood loss in patients of group I amounted to 1642±1146 ml (27.5±22.0% BCC), 26.3% of patients recorded minimal blood loss (700ml). Complications of the postoperative period was observed in 2 (6.25%) patients -in one case there was thrombosis of the common femoral artery requiring thrombectomy and execution in one patient, massive blood loss (4000 ml), filled with large doses of fresh frozen plasma and donor red blood cell mass. In group II, the intraoperative blood loss averaged 1974±1445ml or 29.7±22.4% BCC, the volume of blood loss in one patient, demanded its transfer to the ventilation. Conclusion:Temporary balloon occlusion of the common iliac arteries and uterine artery embolization are effective methods of reducing blood loss during delivery of patients with placenta accretа and uterine scar after cesarean section. With the availability of both techniques, preferably holding a temporary balloon occlusion, providing a significant reduction in blood loss volume.It can be recommended for use in hospitals level III.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.